GENEVA, July 6 -- LUPIN LIMITED filed a patent application (IB2025/063428) for “ORAL FORMULATION OF PIMAVANSERIN”. With publication no. WO/2026/139910, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4468
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....